Active Public Health & Healthcare Digestion, Kidneys & Other Organs

Understanding the clinical pathway for early-stage point-of-care testing of Sepsis

In plain English

AI plain-English summary

A laser physicist will spend time in emergency departments and microbiology labs in the UK, Uganda, and India, watching how doctors currently diagnose sepsis. Sepsis kills quickly and unpredictably, yet existing tests are too slow to guide the first critical treatment decisions in an emergency room. The problem is not just technical—a fast, accurate point-of-care test must work in hospitals with vastly different resources, from a well-stocked NHS trust to a rural Indian clinic. By embedding a physicist in real clinical workflows across three countries, this project aims to map exactly what a useful test needs to measure, how fast it must return results, and what practical constraints—cost, power, training, sample handling—limit its deployment. If successful, the partnership could define the specifications for a genuinely game-changing diagnostic that triages sepsis patients within minutes, not hours, saving lives in both high-income and lower-resource settings. The research does not build the test itself; it builds the essential cross-disciplinary understanding needed to design one that will actually be used.

View original technical description
Sepsis is a poorly understood, complex condition, affecting those of all ages, whose progression is difficult to predict and whose outcome can frequently be fatal. With the possibility for rapid deterioration in a patient’s condition, early identification of Sepsis is essential to improve patient outcomes and improve post-illness quality of life. The objective of this proposal is to build an improved understanding of the clinical testing pathway for early identification of Sepsis and further evaluate the suitability of a clinically relevant test that enables rapid testing at the point-of-care (POC) to advise critical clinical decision-making when treating this condition in an Emergency Department (ED). To develop a genuinely game-changing test, it is essential to bring together the appropriate clinicians and technologists to pinpoint the various testing needs and limitations, and to then deliver an appropriate POC test. Therefore, the proposal aims to develop and sustain a strategic partnership between the investigators across the disciplines of photonics engineering, microbiology, and clinical medicine at the University of Southampton (UoS), University Hospital Southampton NHS Foundation Trust (UHS-NHS), National Microbiology Reference Laboratory (NMRL), Uganda and Sri Devraj Urs Medical College (DUMC), India. Through strategic placements of the UK-investigators, primarily the UoS-based Project Lead (PL): a laser-physicist, within the ED and associated testing laboratory of UHS-NHS, NMRL and DUMC, and the UHS-NHS-based Project Co-Leads (PcLs): an Intensive Care Consultant and a Consultant Medical Microbiologist, for a limited period within NMRL and DUMC, the proposal aims to build a better understanding to address an unmet challenge of configuring and delivering a sepsis-diagnostic, which is equally well-positioned for use in hospitals with different resources and infrastructure. A diagnostic that provides a rapid result delivers a potentially invaluable benefit of saving the lives of those admitted to ED with Sepsis. This invaluable training within different healthcare settings, especially an ED and the associated testing laboratory, will help the PL, as mentioned in the Call: ‘Gain skills and knowledge to answer a specific cross-disciplinary research question’ – rapid POC testing for Sepsis. ‘Understand the drivers for that research challenge and the context in which any solution would be deployed’ – triaging and early diagnosis in hospital EDs. ‘Better identify the healthcare challenges and clinical workflows’ – within ED and testing lab, ‘where EPS (-based PL) has the potential to lead to novel solutions’ - a rapid test for early identification of Sepsis and patient stratification into appropriate treatment units. ‘Broaden their (PL’s) awareness of the current state-of-the art in other scientific (clinical diagnostics) disciplines that are needed to address the research challenge’ – of developing a test routinely employable within hospital EDs for Sepsis. Similarly, the proposed short visits will enable the PcLs to, as stated in the Call: ‘Understand the drivers for that research challenge and the context (lower- and middle-income country, LMIC) in which any solution would be deployed’ – i.e., in comparatively resource-constrained settings of an ED at hospitals in LMICs. ‘Understand the social science and design factors (in a LMIC) that influence the adoption and use of healthcare technologies and patient concordance’ - in LMICs. Finally, both the above will facilitate to ‘strengthen or build new collaborations (between the UK-investigators and those in the LMICs) and carry out broader multi-centre research within health technologies with the collaborators’ towards the end-goal of tackling Sepsis.

View the original record at the funder ↗

Researchers

Ahilanandan Dushianthan (Co-Investigator)Collin Sones (Principal Investigator)Kordo Saeed (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

Improving the management of sepsis through rapid pathogen and antibiotic resistance detection in blood
Development and clinical evidence generation for a rapid, cost-effective, point of care antibiotic susceptibility test for urinary tract infections
IRC Next Steps Plus: Photonic Pathogen Theranostics - Point-of-care image guided photonic therapy of bacterial and fungal infection
Rapid Point of Care Sepsis Diagnostic Platform
iSEP-SEQ: Integrated workflow for SEPsis and infectious diseases diagnosis with a microbial cell-free DNA SEQuencing approach

Original classification

Research and Innovation

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.